Dongzhimen Hospital
Beijing, 100007, China
NCT Number: NCT04636359
This study recruits 30 subjects into three groups, including two experimental groups and one control group. The two experimental groups receive acupuncture treatment for 4 weeks and two times functional magnetic resonance imaging scans as well as clinical symptom assessments. The control group receive one scan without any intervention. The aim of this study is to find the whether the effect of acupuncture treatment have diversity among migraineurs with different disease course.
Looking for future studies?
Notify Me18 year–55 year
All sexes
Interventional
Not applicable
Beijing, 100007, China
This study recruits 10 patients with long course (> 5 years) without aura migraine, 10 patients with short course (< 5 years) without aura migraine and 10 healthy volunteers who meet the inclusion and exclusion criteria. Among the study, two migraine patient groups receive acupuncture treatment for 4 weeks, the frequency is 30 minutes each time, three times a week. According to the national standard of the people's Republic of China (GB / T 12346-2006) acupoint name and location, the acupuncture treatment includes SJ23 (Si Zhu Kong, unilateral), GB8 (Shuai Gu, unilateral), EX-HN5 (Tai Yang, unilateral), GB20 (Feng Chi, unilateral), LI4 (He Gu, bilateral), GB41 (Zu Lin Qi, bilateral), GB34 (Yang Ling Quan, bilateral) and SJ5 (Wai Guan, bilateral) acupoints. Both migraine patients receive scan in functional magnetic resonance imaging (Siemens 3.0T superconducting magnetic resonance scanner, Germany) and symptom scale assessment before the first acupuncture stimulation and post the last acupuncture stimulation. Healthy volunteers receive only one scanning without intervention.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention is about acupuncture treatment, which has 4 weeks acupoint stimulation and the frequency is 30 minutes each times for 3 times per week. The acupoints include SJ23 (Si Zhu Kong, unilateral), GB8 (Shuai Gu, unilateral), EX-HN5 (Tai Yang, unilateral), GB20 (Feng Chi, unilateral), LI4 (He Gu, bilateral), GB41 (Zu Lin Qi, bilateral), GB34 (Yang Ling Quan, bilateral) and SJ5 (Wai Guan, bilateral).
Time frame: Change from Visual Analogue Scale at 1 months.
The headache intensity is measured by the value of Visual Analogue Scale which limits 1 to 10. The higher value of this scale represents the worse headache.
Time frame: Change from the number of day at 1 months.
The days when headache attacked. The increased day represents the worse headache.
Time frame: Change from the times of headache attack at 1 months.
The maximum times in one day during the headache attacked. The increased time represents the worse headache.
Time frame: Changes from the dataset of subject's brain area at 1 months.
Dataset of functional magnetic resonance imaging on brain includes functional images, structural images and diffusion tensor images.
Time frame: Change from the value of Pittsburgh Sleep Quality Index at 1 months.
One of the clinical measurement. The higher value represents the worse quality of sleep.
Time frame: Change from the value of Medical Outcomes Study Short-Form 36 questionnaire at 1 months.
One of the clinical measurement. The value range is 0 to 10, the higher value represents the better quality of life.
Beijing University of Chinese Medicine
Other
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04157192
Acupuncture Therapy, Brain Diseases
Nîmes, France
View Trial DetailsNCT06409845
Brain Diseases, Central Nervous System Diseases
Florence, Italy
View Trial DetailsNCT03461874
Brain Diseases, Central Nervous System Diseases
Milan, Milano, Italy
View Trial DetailsNCT05903040
Brain Diseases, Central Nervous System Diseases
Florence, Italy
View Trial Details